FAM
BCAB

Flaharty Asset Management’s BIOATLA INC BCAB Stock Holding History

Flaharty Asset Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-83
Closed -$1.44K – 164
2025
Q1 		$1.44K Buy
+83
New +$1.77K ﹤0.01% 463

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Flaharty Asset Management's BCAB Position: Q2 2025 in Review

Flaharty Asset Management sold out of BIOATLA INC (BCAB) in Q2 2025, closing a stake of 83 shares — an estimated $1.44K sold.

Flaharty Asset Management first reported a position in BCAB in Q1 2025 and held it in 1 quarter. The position peaked at $1.44K in Q1 2025. 39 funds tracked by Wall St. Rank hold BCAB as of Q2 2025.

  • Flaharty Asset Management reported no remaining BIOATLA INC position as of Q2 2025 after selling out during the quarter.
  • Flaharty Asset Management sold 83 BIOATLA INC shares in Q2 2025, an estimated $1.44K.
  • Flaharty Asset Management first reported a position in BIOATLA INC in Q1 2025 and held it in 1 quarter.
  • Flaharty Asset Management's BIOATLA INC position peaked at $1.44K in Q1 2025.
  • 39 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2025.

Based on Flaharty Asset Management's 13F filing for Q2 2025, filed 8 Aug 2025.